6
Oct
2026

Humanis Saglik A.S.

Exhibitor at CPHI Milan 2026 stand 5D17, Integrated Pharma
About Us

Pharmactive has changed its name to Humanis to design the next decade in diversifying global markets. Humanis, our new name, highlights our human focus and our goal to make health access for everyone.

Established in 2010, with our motto "Happy is the one who offers a cure.", we offer drugs developed with innovative, high quality, and patient-oriented approach in various therapeutic fields for doctors, pharmacists, and patients. It is one of the few leading drug production facilities both in Turkey and Europe thanks to an investment worth $200 million.

Our production facility located in Çerkezköy  on an area of 108,000 square meters boasts a production capacity of 3...

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Türkiye
  • On CPHI since:
    2020
  • Certificates:
    3
  • Employees:
    500 - 999
Company types
Biopharmaceutical company
CMO/CDMO
Drug delivery device Supplier/Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Pharmaceutical Company (generic finished products)
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 5D17, Integrated Pharma

Products Featured at CPHI Milan 2026

Humanis Saglik A.S. Resources (1)

  • Humanis Introduction

    Video Humanis Introduction

    Humanis operates on a human-oriented basis and offers the basic means for healthier living for all. We rely on our innovative powers and agile pharmaceuticals and health products manufacturing capabilities to substantiate our genuine steps toward shaping the future for better health and wellbeing. We materialize innovative ideas around our values, and pledge better health and wellbeing services wherever there are humans.  We aim to grow as a global actor and bring the good around the world by advancing our pharmaceuticals and health products manufacturing capabilities based on technology. We make a difference with our R&D center, and export our products to 50+ countries. We conduct indoor manufacturing operations in a 45.000 sqm area and have a potential utility space of 108.000 sqm, generating up to 330 million units a year.
    2025-09-16